Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Unfold Productions, Dr. Marie McNeely, and The Partnership for Clean Competition. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Unfold Productions, Dr. Marie McNeely, and The Partnership for Clean Competition or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

118 - Developing Novel Methods and Biomarkers to Detect Growth Hormone Doping - Martin Bidlingmaier, MD

54:13
 
Share
 

Manage episode 395668635 series 2698152
Content provided by Unfold Productions, Dr. Marie McNeely, and The Partnership for Clean Competition. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Unfold Productions, Dr. Marie McNeely, and The Partnership for Clean Competition or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Dr. Martin Bidlingmaier is Head of the Endocrine Laboratory, and he leads the Neuroendocrine Research Group in the Department of Internal Medicine at the Ludwig-Maximilians-University of Munich. Martin conducts clinical and basic research, particularly focusing on the development and validation of laboratory methods to diagnose and monitor pituitary and adrenal hormones, physiology, pathophysiology and biomarkers of growth hormone action, and endocrine aspects of doping in sports. In this episode, we discuss his work identifying new biomarkers and developing novel methods to measure growth hormone and detect growth hormone doping. He describes how growth hormone isoforms and the formation of complexes can help distinguish doping, and how the protein soluble α-klotho has emerged as a potential biomarker that may be useful in anti-doping analyses.

  continue reading

151 episodes

Artwork
iconShare
 
Manage episode 395668635 series 2698152
Content provided by Unfold Productions, Dr. Marie McNeely, and The Partnership for Clean Competition. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Unfold Productions, Dr. Marie McNeely, and The Partnership for Clean Competition or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Dr. Martin Bidlingmaier is Head of the Endocrine Laboratory, and he leads the Neuroendocrine Research Group in the Department of Internal Medicine at the Ludwig-Maximilians-University of Munich. Martin conducts clinical and basic research, particularly focusing on the development and validation of laboratory methods to diagnose and monitor pituitary and adrenal hormones, physiology, pathophysiology and biomarkers of growth hormone action, and endocrine aspects of doping in sports. In this episode, we discuss his work identifying new biomarkers and developing novel methods to measure growth hormone and detect growth hormone doping. He describes how growth hormone isoforms and the formation of complexes can help distinguish doping, and how the protein soluble α-klotho has emerged as a potential biomarker that may be useful in anti-doping analyses.

  continue reading

151 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play